Summary
Complications arising from difficulty controlled bleeding and thrombus formation during procedures which require extracorporeal circulation with heparin as anticoagulant motivate the search for better hemostasis and anticoagulant technology. An enzyme (Defibrase), having a specific interaction with fibrinopeptide A such as to cause fibrin depletion in a soluble form, has been proposed as an alternative to heparin. Defibrase, in contrast to heparin, does not affect blood platelet function. Heparin and Defibrase as anticoagulants were compared in 8 h perfusion studies using arterio-venous extracorporeal blood circuits in dogs; the circuitry included pumps, membrane oxygenators and filters serially. Thrombus formation, in the filters and the oxygenators as well as pathology of the perfused animal were investigated. The results suggest that defibrase-like enzymes have potential for enhanced control of hemorrhagic and thrombotic phenomena. Although impeded by a latency of several hours before the full anticoagulant properties are developed in vivo, it appears that enzymatically mediated defibrinogenation of blood may be a valuable alternative to heparinization in extracorporeal circulation procedures.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Guidoin R, Awad J, Domurado D (1976) Thrombus formation and microaggregate removal during prolonged extracorporeal circulation using a capillary membrane oxygenator. Res Exp Med 168:65
Guidoin R, Awad J, Domurado D, Haggis GH (1978) Thrombus formation in a staged capillary membrane oxygenator associated with a microaggregate blood filter: a scanning electron microscope study. J Biomed Mater Res 12:255
Dutton RC, Edmunds LH Jr (1974) Formation of platelet aggregate emboli in a prototype hollow fiber membrane oxygenator. J Biomed Mater Res 8:163
Lautier A, Bonnet A, Volter F, Mong-Hung B, Laurent D (1974) Studies on oxygenator membrane surface in long-term extracorporeal assistance. Trans Am Soc Artif Int Org 20:307
Schneider MD (1973) Nature of thrombus in a hollow fiber oxygenator. Am J Vet Res 34:151
Guidoin R, Kenedi RM, Trudell L, Galletti P, Blais P (1979) Thrombus formation and microaggregate removal during extracorporeal membrane oxygenation. J Biomed Mater Res 13:317
Kolobow T, Stool EW, Weathersby PK, Peirce J, Heyano F, Suaudeau J (1974) Superior blood compatibility of silicone rubber free of silica filler in the membrane lung. Trans Am Soc Artif Int Org 20:269
Hagler HK, Powell WM, Eberle MW, Sugg WL, Platt MR, Watson JT (1975) Five-day partial by-pass using a membrane oxygenator without systemic heparinization. Trans Am Soc Artif Int Org 21:178
Salzman E, Deykin D, Shapiro R, Rosenberg R (1975) Management of heparin therapy: controlled prospective trial. N Engl J Med 292:1046
Abbott WM, Warnock DF, Austen WG (1977) The relationship of heparin source to the incidence of delayed hemorrhage. J Surg Res 22:593
Büky B, Bell W, Matthews P, Reidy T, White JJ (1973) Arvin anticoagulation for prolonged extracorporeal membrane oxygenation. Trans Am Soc Artif Int Org 19:56
Berglin E, Svalander C, Teger-Nilsson AC, William-Olsson G (1976) Anticoagulation with defibrase during prolonged extracorporeal circulation in the dog. Scand J Thor Cardiovasc Surg 10:225
Berglin E, Hansson HA, Teger-Nilsson AC, William-Olssen G (1976) Defibrinogenation as an alternative to heparinization during prolonged extracorporeal circulation in the dog. Thromb Res 9:81
Swank RL, Roth JG, Jansen J (1964) Screen filtration pressure method, adhesiveness, and aggregation of blood cells. J App Physiol 19:340
Hattersley PG (1966) Activated coagulation time of whole blood. J Am Med Assoc 196:436
Egberg N (1973) Experimental and clinical studies on the thrombin-like enzyme from the venom of Bothrops Atrox on the primary structure of fragment E. PhD Thesis. Karolinska Institutet, Stockholm
Guidoin RG, Sirois M, Awad J, Rousseau C (1974) Vitesse de métabolisation de l'héparine chez le chien. Exp Animale 7:15
Olssen P, Blombäck M, Egberg N, Ekeström S, Göransson L, Johnsson H (1971) Studies on the bleeding tendency and on the possibility of surgery in states of reptilase induced defibrinogenation. Thromb Diathes Haem Sup 47:387
Meissner AG, O'Sullivan G, Macbeth RA (1976) The effect of defibrinogenation on pulmonary embolism in dogs. Thromb Haemostas (Stuttg) 36:140
Young JA, Kisken T, Doty DB (1978) Adequate anticoagulation during cardiopulmonary bypass determined by activated clotting time and the appearance of fibrin monomers. Ann Thorac Surg 26:231
Berglin E, Swalander C, Teger-Wilsson AC, William-Olsson G (1978) Administration of plasma to dogs defibrinogenated with defibrose. Thromb Res 13:785
Berglin E, Hansson HA, William-Olsson G (1979) Plasma administration to defibrinogenated dogs during extracorporeal circulation. Art Org 3:80
Berglin E (1978) Extracorporeal circulation in defibrinogenated dogs. PhD thesis, Göteborg
Loop FD, Szabo J, Rowlinson RD, Urbanek K (1976) Events related to microembolism during extracorporeal perfusion in man: effectiveness of in-line filtration recorded by ultrasound. Ann Thorac Surg 21:412
Abts L, Beyer R, Galletti P, Richardson P, Karon D, Massimino R, Karlson K (1978) Computerized discrimination of microemboli in extracorporeal circuits. Am J Surg 135:535
Fletcher JR, McKee A, Watson L, Anderson RD (1979) Veno-arterial cardiopulmonary by-pass without heparin in the baboon. ASAIO 2:17
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roy, J., Guidoin, R., Martin, L. et al. Defibrinogenation as an alternative to heparinization in prolonged extracorporeal circulation. Res. Exp. Med. 176, 219–234 (1980). https://doi.org/10.1007/BF01855842
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01855842